RU2006146555A - Инъецируемые фармацевтические композиции позаконазола со стабилизированными частицами - Google Patents

Инъецируемые фармацевтические композиции позаконазола со стабилизированными частицами Download PDF

Info

Publication number
RU2006146555A
RU2006146555A RU2006146555/15A RU2006146555A RU2006146555A RU 2006146555 A RU2006146555 A RU 2006146555A RU 2006146555/15 A RU2006146555/15 A RU 2006146555/15A RU 2006146555 A RU2006146555 A RU 2006146555A RU 2006146555 A RU2006146555 A RU 2006146555A
Authority
RU
Russia
Prior art keywords
posaconazole
composition according
composition
average
max
Prior art date
Application number
RU2006146555/15A
Other languages
English (en)
Russian (ru)
Inventor
Леонор ВИТЧИ-ЛАКШМАНАН (US)
Леонор ВИТЧИ-ЛАКШМАНАН
Сидней УГВУ (US)
Сидней УГВУ
Варда ЗАНДВАЙСС (US)
Варда ЗАНДВАЙСС
Кэтрин ХАРДЭЛО (US)
Кэтрин ХАРДЭЛО
Роберта ХЕА (US)
Роберта ХЕА
Гопал КРИШНА (US)
Гопал Кришна
Зайки ВАНГ (US)
Зайки ВАНГ
Марко ТАЛЬИЕТТИ (US)
Марко ТАЛЬИЕТТИ
Original Assignee
Шеринг Копрорейшн (Us)
Шеринг Копрорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34971355&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2006146555(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Шеринг Копрорейшн (Us), Шеринг Копрорейшн filed Critical Шеринг Копрорейшн (Us)
Publication of RU2006146555A publication Critical patent/RU2006146555A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2006146555/15A 2004-05-28 2005-05-27 Инъецируемые фармацевтические композиции позаконазола со стабилизированными частицами RU2006146555A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57512604P 2004-05-28 2004-05-28
US60/575,126 2004-05-28

Publications (1)

Publication Number Publication Date
RU2006146555A true RU2006146555A (ru) 2008-07-20

Family

ID=34971355

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006146555/15A RU2006146555A (ru) 2004-05-28 2005-05-27 Инъецируемые фармацевтические композиции позаконазола со стабилизированными частицами

Country Status (15)

Country Link
EP (1) EP1761247A1 (cg-RX-API-DMAC7.html)
JP (1) JP2008501034A (cg-RX-API-DMAC7.html)
KR (1) KR20070027564A (cg-RX-API-DMAC7.html)
CN (1) CN1988887A (cg-RX-API-DMAC7.html)
AR (1) AR049063A1 (cg-RX-API-DMAC7.html)
AU (1) AU2005249502A1 (cg-RX-API-DMAC7.html)
CA (1) CA2567803A1 (cg-RX-API-DMAC7.html)
IL (1) IL179627A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA06013886A (cg-RX-API-DMAC7.html)
NO (1) NO20066005L (cg-RX-API-DMAC7.html)
PE (1) PE20060291A1 (cg-RX-API-DMAC7.html)
RU (1) RU2006146555A (cg-RX-API-DMAC7.html)
TW (1) TWI290051B (cg-RX-API-DMAC7.html)
WO (1) WO2005117831A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200609890B (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060009469A1 (en) * 2004-05-28 2006-01-12 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmacutical compositions of posaconazole
WO2007131253A2 (de) 2006-05-12 2007-11-22 Pharmacon-Forschung Und Beratung Gmbh Verwendung von kombinationspräparaten, umfassend antimykotika
EP2130540A1 (en) * 2008-06-02 2009-12-09 Sandoz AG Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
CA2767489A1 (en) 2009-07-09 2011-01-13 Sandoz Ag A crystalline form of posaconazole
US9073904B2 (en) 2010-05-19 2015-07-07 Sandoz Ag Preparation of posaconazole intermediates
EP2571847B1 (en) 2010-05-19 2016-09-21 Sandoz AG Process for the preparation of chiral hydrazides
CN102892763B (zh) 2010-05-19 2016-03-09 桑多斯股份公司 泊沙康唑及泊沙康唑中间体的纯化
AU2011254654B2 (en) 2010-05-19 2016-01-07 Sandoz Ag Process for the preparation of chiral triazolones
PL3391890T3 (pl) * 2010-06-29 2021-12-20 Merck Sharp & Dohme Corp. Preparaty dożylnego roztworu pozakonazolu stabilizowane podstawioną beta-cyklodekstryną
CN103635465A (zh) 2011-06-16 2014-03-12 桑多斯股份公司 制备手性化合物的方法
CN103284959B (zh) * 2012-02-22 2015-06-03 重庆圣华曦药业股份有限公司 泊沙康唑冻干粉针剂及制备方法
CN102755628B (zh) * 2012-07-16 2013-10-23 中国科学院微生物研究所 一种抗真菌的药物组合物
CN102805731B (zh) * 2012-08-22 2014-04-30 北京莱瑞森医药科技有限公司 泊沙康唑干混悬剂及其制备方法
CN105030668B (zh) * 2015-06-26 2018-03-27 济川药业集团有限公司 泊沙康唑口服混悬剂及其制备方法
CN106333925B (zh) * 2015-07-10 2019-06-18 上海美悦生物科技发展有限公司 一种泊沙康唑液体混悬剂及其制备方法
CN105997872B (zh) * 2016-07-08 2019-02-19 河南省立眼科医院 一种含有泊沙康唑的眼用纳米胶束抗真菌溶液
CN110582264B (zh) * 2017-03-26 2022-11-11 V·R·斯塔福德 眼睑皮肤状况的处理方法
AU2018253189A1 (en) * 2017-04-12 2019-12-05 Vikash J. BHAGWANDIN Compositions, packaged pharmaceuticals, and methods of using posaconazole for the sensitization of resistant tumors
CN110507609B (zh) * 2018-05-21 2021-09-17 上海医药工业研究院 泊沙康唑口服混悬剂的制备方法
CN111514146A (zh) * 2020-04-28 2020-08-11 山西振东泰盛制药有限公司 含有泊沙康唑的药物组合物
CN113933131B (zh) * 2021-09-24 2024-01-26 合肥天一生物技术研究所有限责任公司 一种阴道微生物荧光染色液

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091188A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
PL212985B1 (pl) * 2001-04-03 2012-12-31 Schering Corp Ciekla zawiesina zawierajaca przeciwgrzybiczo skuteczna ilosc posakonazolu oraz zastosowanie zmikronizowanych czastek posakonazolu

Also Published As

Publication number Publication date
JP2008501034A (ja) 2008-01-17
PE20060291A1 (es) 2006-04-14
MXPA06013886A (es) 2007-01-26
AR049063A1 (es) 2006-06-21
KR20070027564A (ko) 2007-03-09
EP1761247A1 (en) 2007-03-14
CN1988887A (zh) 2007-06-27
AU2005249502A1 (en) 2005-12-15
ZA200609890B (en) 2008-09-25
WO2005117831A1 (en) 2005-12-15
CA2567803A1 (en) 2005-12-15
TW200609001A (en) 2006-03-16
TWI290051B (en) 2007-11-21
NO20066005L (no) 2007-02-27
IL179627A0 (en) 2007-05-15

Similar Documents

Publication Publication Date Title
US8551942B2 (en) Lyophilized anti-fungal compositions
US8431539B2 (en) Formulations of daptomycin
US11819533B2 (en) Compositions and methods for the treatment of fungal infections
US9393307B2 (en) Caspofungin composition
US8980827B2 (en) Medicinal composition containing echinocandin antifungal agent micafungin and preparation method and use thereof
EP1761247A1 (en) Injectable pharmaceutical suspension comprising posaconazole
NZ516108A (en) Ophthalmic composition containing ketotifen and a non-ionic tonicity agent
TW200423871A (en) Topical parasiticide formulations and methods of treatment
CN101351219A (zh) 包含增效比例的干扰素γ和α的稳定的制剂
US11931362B2 (en) Stable pharmaceutical formulations of pemetrexed
TWI920017B (zh) 用於治療真菌感染之化合物及方法
WO2021058014A1 (zh) 奥硝唑类药物组合物及其制备方法和用途
US20100210681A1 (en) Aqueous pharmaceutical composition
JP2007535545A (ja) 難吸収性薬剤の経口投与のための製剤
CN116251168A (zh) 一种棘白素类似物的药物组合物及其制备方法
SK8702001A3 (en) Cyclosporin solution
OA20177A (en) Compounds and methods for treating fungal infections.
EP3829586A1 (en) Combination therapy for treating cancer
TW202529794A (zh) 液態西曲瑞克(Cetrorelix)組合物
US20240180935A1 (en) Solution formulation of cyclophosphamide
EA053006B1 (ru) Фармацевтическая композиция, содержащая аналог эхинокандина, и способ получения фармацевтической композиции
RU2333766C2 (ru) Способы введения далбаванцина для лечения бактериальных инфекций
JP2025535828A (ja) エキノカンジン類似体の医薬組成物及びその調製方法
CN121197150A (zh) 包含奥硝唑类化合物的药物组合物及其制备方法和用途
EP4719400A1 (en) Oral pharmaceutical composition of isavuconazonium or its pharmaceutically acceptable salts thereof

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20090929